Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Navigare Ventures is an early-stage venture capital firm based in Stockholm, Sweden, and operates as a fully owned subsidiary of Wallenberg Investments AB. The firm focuses on investing in science-driven companies, aiming to enhance the industrial and societal impact of research. Their portfolio currently includes 10 companies, reflecting a commitment to deep tech innovation.
Navigare Ventures specializes in Seed and Series A investments in deep tech sectors, including applied mathematics, AI, quantum technologies, and life sciences. Their investment themes revolve around the Future of Computing, Shaping Matter, and Understanding Life, targeting companies that demonstrate scientific excellence and strong business acumen.
Notable portfolio companies include Elypta, which develops metabolism-based liquid biopsy technology for early cancer detection; Arevo, innovating climate-smart amino acid fertilizer technologies; ScandiBio, utilizing AI-driven models for therapies targeting metabolic dysfunction; and Pixelgen, offering a molecular assay for studying single cells. Other companies in their portfolio include Rarity Bioscience, EnginZyme, AlixLabs, Profundus, Interspectral, and SweGaN.
Email info@navigareventures.com with your deck to pitch them directly.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.